view counter

Category: Stem CellsSyndicate content

U.S. asks for stem cell ruling stay

August 31, 2010 by MassDevice staff

The U.S. Justice Dept. asks Judge Royce Lamberth to stay a ruling barring federal funding of research using embryonic stem cells pending an appeal.

Gavel logo

The U.S. Justice Dept. asked a federal judge to stay ruling barring federal funding of research that uses embryonic stem cells, citing the "magnitude of harms occurring each day that the preliminary injunction remains in effect," according to news reports.

MedGadget's MedTech Monday: Synthetic cornea offers performance on par with cadaver cornea after two years

August 30, 2010 by MassDevice

Synthetic cornea offers performance on par with cadaver cornea after two years; pocket-sized CPR-assistance device with Analog Devices' iMEMS; engineering polymer surfaces to promote stem cell growth; DNA-based artificial nose senses organic vapors.

MedGadget's MedTech Monday: Synthetic cornea offers performance on par with cada

Synthetic cornea offers performance on par with cadaver cornea after two years: A small (n=10) Phase 1 study published in Science Translational Medicine last week showed that synthetic corneas performed as well as cadaver harvested corneas over a 24-month followup. The paper's authors wrote, "The biosynthetic implants remained stably integrated and avascular for 24 months after surgery, without the need for long-term use of the steroid immunosuppression that is required for traditional allotransplantation.

Neuralstem aims to treat paralysis in spinal injury stem cell trial

August 27, 2010 by MassDevice staff

Neuralstem Inc. files an Investigational New Drug application with the Food & Drug Administration to begin a clinical trial for a stem cell treatment of paralysis from spinal cord injuries.

Neuralstem logo

Neuralstem Inc. (AMEX:CUR) asked the Food & Drug Administration for permission to begin a clinical trial of a chronic spinal injury treatment using stem cells.

The Rockville, Md.-based company's Phase I clinical safety trial would employ its adult stem cell technology with cells derived from spinal cords to treat 16 patients with American Spinal Injury Assn. Grade A level of impairment, or complete paralysis, one to two years after the injury that caused their condition.

ThermoGenesis to mount reverse stock split

August 26, 2010 by MassDevice staff

ThermoGenesis Corp. consolidates its stock to stave off a possible de-listing from the NASDAQ exchange.

ThermoGenesis logo

ThermoGenesis Corp. (NSDQ:KOOL) will reverse-split its stock tomorrow.

The board of the Rancho Cordova, Calif.-based company approved the move in an attempt to boost its share price. ThermoGenesis faces being de-listed from the NASDAQ stock exchange unless it meets the market's minimum $1-per-share requirement.

Obama appeals stem cell ruling

August 25, 2010 by MassDevice staff

President Barack Obama's administration will appeal a controversial legal decision temporarily barring federal funding of research involving embryonic stem cells.

gavel

President Barack Obama's administration will appeal a controversial ruling issued earlier this week that put a temporary stop to federal funding of research involving stem cells derived from human embryos, according to news reports.

Federal judge nixes embryonic stem cell research

August 24, 2010 by MassDevice staff

A federal judge in Washington, D.C., temporarily bans the federal government from funding research involving embryonic stem cells, dealing a blow to medical research but heartening Christian groups opposed to research using cells derived from human embryos.

gavel

A federal judge temporarily halted federal funding of research using embryonic stem cells, creating consternation among medical researchers and celebration among Christian activists opposed to the research.

UMinn researchers use bone marrow stem cells to repair skin

August 12, 2010 by MedCity News

Researchers at the University of Minnesota use stem cells derived from bone marrow to repair damaged skin.

MedCity News logo

University of Minnesota researchers have successfully repaired damaged skin tissue using stem cells gleaned from bone marrow.

In a study published today in the New England Journal of Medicine, researchers from the school’s Stem Cell Institute said the therapy can help patients who suffer from recessive dystrophic epidermolysis bullosa, a painful genetic skin disorder that causes skin to blister and scrape off at the slightest friction or trauma.

Support the news, become a MassDevice.com insider
view counter
META's Needs Assessment System measures the gap between ideal and current sales performance
view counter

Preferred Vendors

Assay Testing, Other

Instron
Precision testing instrumentation and services for materials, components, and structures in R&D, Quality Control and Production environments.

Legal

Greenberg Traurig LLP
Provides legal services

Reimbursement, Salesforce Development and Training, Reimbursement

Medical Education Training Associates LLC (META)
Provides a suite of consulting services for medical device companies
Reimbursement Planning, Health Policy Training
Salesforce development and Management training

Plastics / Molded Products, Original Equipment Manufacturer

SMC Ltd. (Scientific Molding Corp.)
Manufactures injection-molded, single-use disposable medical devices

Communications / PR, Marketing

Seidler Bernstein
Provides marketing and PR services

Publishing, Software / IT, Consulting

Cine-Med Inc.
Produces medical films and publishes continuing education. materials for medical device companies

Consulting, Legal

National Standards Authority of Ireland
Provides regulatory compliance services

Original Equipment Manufacturer

Admet
Static and Dynamic testing systems for materials, components, and devices. Systems range from 50 grams to 600kN of force capacity in tension, compression, torsion, and more.
Provides grips, fixtures, heating and cooling systems, and fluid baths.
McClellan Automation Systems
Manufactures custom automated systems and special process machinery

Machining, Prototype Manufacturing, Design / Engineering

Roush Life Sciences
Provides design and engineering, rapid prototyping, tooling, engineering and manufacturing services for life science companies
A Division of Roush Enterprises

Consulting, Regulatory

Emergo Group, Inc.
Regulatory charts and consulting
view counter
view counter
PACIFIC BRIDGE MEDICAL (PBM) is a leading Asia medical consulting firm dedicated to assisting medical companies in Asia.
view counter
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp